Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical-Use-Associated Decrease in Susceptibility of Vancomycin-Resistant Enterococcus faecium to Linezolid: a Comparison with Quinupristin-Dalfopristin

24 Aug 2004

Abstract excerpt

The susceptibility of 135 vancomycin-resistant Enterococcus faecium bacteremic isolates to linezolid and quinupristin-dalfopristin was determined. All were susceptible to linezolid, while 88% were susceptible to quinupristin-dalfopristin prior to the clinical use of the drugs at our hospital. More than 6 months after their clinical use, a decrease in susceptibility was noted for only linezolid at 83%. This was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Bacterial biofilms and quorum sensing
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15328133
DOI: 10.1128/aac.48.9.3583-3585.2004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical-Use-Associated Decrease in Susceptibility of Vancomycin-Resistant Enterococcus faecium to Linezolid: a Comparison with Quinupristin-DalfopristinPMID 15328133Read ↗

Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.Semantic proximity Read ↗

Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.Semantic proximity Read ↗

Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption.Semantic proximity Read ↗

Linezolid-Resistant, Vancomycin-Resistant Enterococcus faecium Infection in Patients without Prior Exposure to LinezolidSemantic proximity Read ↗

Enterococcus faecalis Resistant to Linezolid: Case Series and Review of the LiteratureSemantic proximity Read ↗

Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada.Semantic proximity Read ↗

Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patientsSemantic proximity Read ↗

Linezolid-resistant enterococci: report of the first isolates in the United KingdomSemantic proximity Read ↗

Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital.Semantic proximity Read ↗

[Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].Semantic proximity Read ↗

Differences in clinical outcomes in patients with vancomycin-resistant enterococci according to linezolid susceptibility.Semantic proximity Read ↗

Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.